SkinMedica Inc. Sustainability Profile
SkinMedica Inc., a leading name in the skincare industry, is headquartered in the United States and operates extensively across North America and beyond. Founded in 1997, the company has established itself as a pioneer in advanced skincare solutions, focusing on innovative products that promote skin health and rejuvenation. SkinMedica is renowned for its scientifically formulated skincare products, including its flagship TNS Essential Serum, which harnesses the power of growth factors to enhance skin appearance. The brand's commitment to research and development has positioned it as a trusted choice among dermatologists and skincare professionals. With a strong market presence and a reputation for quality, SkinMedica continues to achieve notable milestones, solidifying its status as a leader in the aesthetic skincare sector. The company’s dedication to effective, clinically-backed formulations sets it apart in a competitive landscape.
DitchCarbon Score
How does SkinMedica Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SkinMedica Inc.'s score of 65 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SkinMedica Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of AbbVie Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation. As part of its climate strategy, SkinMedica Inc. aligns with initiatives from AbbVie Inc., which has set various reduction targets and participates in industry-standard frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for SkinMedica Inc. are not detailed in the available information. The absence of direct emissions data suggests that SkinMedica Inc. is still in the process of establishing its own climate commitments or may rely on the broader corporate strategies of AbbVie Inc. to guide its environmental impact efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 402,448,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - |
How Carbon Intensive is SkinMedica Inc.'s Industry?
How Carbon Intensive is SkinMedica Inc.'s Location?
SkinMedica Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SkinMedica Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
